These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3637272)

  • 1. [A physician's personal account on the experience with cancer. 3. The result of the pathological diagnosis].
    Osakabe Y
    Kangogaku Zasshi; 1986 Mar; 50(3):318-21. PubMed ID: 3637272
    [No Abstract]   [Full Text] [Related]  

  • 2. [A physician's personal account on the experience with cancer. 6. A visit to a church].
    Osakabe Y
    Kangogaku Zasshi; 1986 Jun; 50(6):684-7. PubMed ID: 3637312
    [No Abstract]   [Full Text] [Related]  

  • 3. [A physician's personal account on the experience with cancer. 5. Life at the hospital].
    Osakabe Y
    Kangogaku Zasshi; 1986 May; 50(5):564-7. PubMed ID: 3637293
    [No Abstract]   [Full Text] [Related]  

  • 4. A terrible beauty: a physician's story of ovarian cancer.
    Spano LJ
    Can Fam Physician; 2007 Jun; 53(6):983-5. PubMed ID: 17872763
    [No Abstract]   [Full Text] [Related]  

  • 5. A personal cancer ordeal sheds new light on practice.
    Young N
    Nurs Times; 2001 Jul 19-25; 97(29):38-9. PubMed ID: 11957504
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychosocial aspects of predictive gene diagnosis in familial breast and ovarian carcinomas].
    von der Groeben C; Neef K; Rohde A; Bodden-Heidrich R; Schmutzler RK
    Dtsch Med Wochenschr; 1999 Mar; 124(12):361-2. PubMed ID: 10214370
    [No Abstract]   [Full Text] [Related]  

  • 7. An ovarian cancer diagnosis-seeking process: unraveling the diagnostic delay problem.
    Koldjeski D; Kirkpatrick MK; Swanson M; Everett L; Brown S
    Oncol Nurs Forum; 2005 Sep; 32(5):1036-42. PubMed ID: 16136201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physician's choice in patients with recurrent platinum-resistant ovarian cancer.
    Cree IA; Kurbacher CM; Lamont A; Hindley AC; Love S;
    Anticancer Drugs; 2007 Oct; 18(9):1093-101. PubMed ID: 17704660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety and prevalence of psychiatric disorders among patients awaiting surgery for suspected ovarian cancer.
    Sukegawa A; Miyagi E; Asai-Sato M; Saji H; Sugiura K; Matsumura T; Kamijyo A; Hirayasu Y; Okamoto N; Hirahara F
    J Obstet Gynaecol Res; 2008 Aug; 34(4):543-51. PubMed ID: 18937707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage I ovarian cancer cases during early, mid and late pregnancy periods: three case reports and review of the literature.
    Hasegawa T; Ishii Y; Yonezawa R; Yoneda N; Shima T; Nakashima A; Hidaka T; Saito S
    J Obstet Gynaecol Res; 2011 Jun; 37(6):650-5. PubMed ID: 21159046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer.
    Fitch MI; Turner F
    Can Nurse; 2006 Jan; 102(1):16-20. PubMed ID: 16468226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living with cancer: perspectives on a five year journey.
    Strumpf NE; Buhler-Wilkerson K
    Nurs Clin North Am; 2010 Sep; 45(3):475-89. PubMed ID: 20804891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.
    Calhoun EA; Fishman DA; Lurain JR; Welshman EE; Bennett CL
    Gynecol Oncol; 2004 Apr; 93(1):164-9. PubMed ID: 15047231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer patient surveillance after curative-intent initial treatment.
    Harmandayan GZ; Gao F; Mutch DG; Virgo KS; Gibb RK; Johnson FE
    Gynecol Oncol; 2011 Feb; 120(2):205-8. PubMed ID: 21075437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When your patient has ovarian cancer.
    Ivey CL
    RN; 1994 Nov; 57(11):26-31; quiz 32. PubMed ID: 7984877
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer killer may be "silent" no more.
    Twombly R
    J Natl Cancer Inst; 2007 Sep; 99(18):1359-61. PubMed ID: 17848663
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in cancer worry associated with participation in ovarian cancer screening.
    Andersen MR; Drescher CW; Zheng Y; Bowen DJ; Wilson S; Young A; McIntosh M; Mahony BS; Lowe KA; Urban N
    Psychooncology; 2007 Sep; 16(9):814-20. PubMed ID: 17225260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well informed?
    Karani D; Wiltshaw E
    Cancer Nurs; 1986 Oct; 9(5):238-42. PubMed ID: 3640673
    [No Abstract]   [Full Text] [Related]  

  • 19. The management of anxiety and knowledge of serum CA-125 after an ovarian cancer diagnosis.
    Reid A; Ercolano E; Schwartz P; McCorkle R
    Clin J Oncol Nurs; 2011 Dec; 15(6):625-32. PubMed ID: 22119973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.